These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2143601)

  • 1. Progress in applied chemoprevention research.
    Kelloff GJ; Malone WF; Boone CW; Sigman CC; Fay JR
    Semin Oncol; 1990 Aug; 17(4):438-55. PubMed ID: 2143601
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal retinal function associated with fenretinide, a synthetic retinoid.
    Kaiser-Kupfer MI; Peck GL; Caruso RC; Jaffe MJ; DiGiovanna JJ; Gross EG
    Arch Ophthalmol; 1986 Jan; 104(1):69-70. PubMed ID: 2935125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The scientific basis for regarding vitamin A and its analogues as anti-carcinogenic agents.
    Hicks RM
    Proc Nutr Soc; 1983 Jan; 42(1):83-93. PubMed ID: 6220411
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
    Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
    Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate intraepithelial neoplasia in Noble rats, a potential intermediate endpoint for chemoprevention studies.
    Christov KT; Moon RC; Lantvit DD; Boone CW; Kelloff GJ; Steele VE; Lubet RA; Pezzuto JM
    Eur J Cancer; 2004 Jun; 40(9):1404-11. PubMed ID: 15177500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of fenretinide-induced apoptosis.
    Hail N; Kim HJ; Lotan R
    Apoptosis; 2006 Oct; 11(10):1677-94. PubMed ID: 16850162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients.
    Formelli F; Carsana R; Costa A; Buranelli F; Campa T; Dossena G; Magni A; Pizzichetta M
    Cancer Res; 1989 Nov; 49(21):6149-52. PubMed ID: 2529028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another negative chemoprevention trial: what can we learn?
    Meyskens FL
    Clin Cancer Res; 2008 Jan; 14(1):2-3. PubMed ID: 18172244
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I chemoprevention study of piroxicam and alpha-difluoromethylornithine.
    Carbone PP; Douglas JA; Larson PO; Verma AK; Blair IA; Pomplun M; Tutsch KD
    Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):907-12. PubMed ID: 9796636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives and progress in development of breast cancer chemopreventive drugs.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk ET; Steele VE; Lubet RA; Sigman CC
    Prog Clin Biol Res; 1997; 396():159-83. PubMed ID: 9108597
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
    Singh J; Kelloff G; Reddy BS
    Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoprevention of colon cancer by dietary administration of naturally-occurring and related synthetic agents.
    Reddy BS
    Adv Exp Med Biol; 1997; 400B():931-6. PubMed ID: 9547649
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppression.
    Xu H; Cheepala S; McCauley E; Coombes K; Xiao L; Fischer SM; Clifford JL
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):969-79. PubMed ID: 16467112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of spontaneous tumorigenesis in p53-knockout mice.
    Hursting SD; Perkins SN; Haines DC; Ward JM; Phang JM
    Cancer Res; 1995 Sep; 55(18):3949-53. PubMed ID: 7664260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents.
    Schwartz AG; Whitcomb JM; Nyce JW; Lewbart ML; Pashko LL
    Adv Cancer Res; 1988; 51():391-424. PubMed ID: 2975913
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemoprevention of breast cancer with retinoids.
    Veronesi U; De Palo G; Costa A; Formelli F; Marubini E; Del Vecchio M
    J Natl Cancer Inst Monogr; 1992; (12):93-7. PubMed ID: 1535505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difluoromethylornithine in cancer: new advances.
    Alexiou GA; Lianos GD; Ragos V; Galani V; Kyritsis AP
    Future Oncol; 2017 Apr; 13(9):809-819. PubMed ID: 28125906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of human skin cancers.
    Loescher LJ; Meyskens FL
    Semin Oncol Nurs; 1991 Feb; 7(1):45-52. PubMed ID: 2011658
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention strategies utilizing combinations of inhibitors of carcinogenesis.
    Malone WF; Kelloff GJ
    J Natl Cancer Inst; 1989 Jun; 81(11):824. PubMed ID: 2498523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.